Artificial intelligence for human age-reversal

Insilico Medicine develops the advanced artificial intelligence (AI) algorithms to study the ageing processes and discover new interventions in ageing, many of these molecules aim to induce the expression of certain genes involved in the endogenous repair processes to slow down and even reverse some of the aging-associated diseases. By applying a specific branch of artificial intelligence called Deep Learning (DL) on multi-modal data, the company aims to discover molecules that can stimulate the repair of the DNA. The objective of this collaboration is to increase health span for everyone on the planet. "Many of the diseases of aging are associated with the failure of the DNA repair mechanisms. The ageing processes accelerate as the DNA repair mechanisms lose function. The collaboration with Insilico Medicine will allow us to find the molecules that repair DNA and prevent accelerated ageing", said the head of the biology of ageing lab and Assistant Professor Morten Scheibye-Knudsen, Center for Healthy Ageing.